“…Overall, taking into account the radiotracer uptake and TBR values, compared to [ 18 F]F-FDG PET, an equal or higher detection of primary tumors and/or metastatic lesions was usually demonstrated by using radiolabeled FAPI PET [ 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 ]. In particular, the cancer entities with better detection rate of tumor lesions by using radiolabeled FAPI PET compared to [ 18 F]F-FDG PET were gastrointestinal tumors, liver tumors, breast cancer and nasopharyngeal carcinoma.…”